首页 | 官方网站   微博 | 高级检索  
     


Intravaginal Controlled Administration of Flurogestone Acetate: (III) Development of Rate-Control Vaginal Devices
Authors:Mohan Kabadi  Yie W Chien
Affiliation:  a Controlled Drug Delivery Research Center Rutgers University College of Pharmacy Busch Campus, Piscataway, New Jersey b Recipient of Synkron Graduate Research Fellowship, Morris Plains, NJ c Controlled Drug Delivery Research Center, College of Pharmacy, Rutgers University, Piscataway, New Jersey
Abstract:A Rate-Control vaginal device was developed which overcomes the low bioavailability and unpredictable Q - t1/2 type release and absorption rate profiles of flurogestone acetate delivered by the currently marketed Syncro-Mate pessary.

The in vitro release and vaginal absorption profiles from the Rate-Control vaginal device were run simultaneously, a linear Q - t relationship was obtained with a significant improvement in bioavailability. A mathematical model was developed to correlate the in vitro drug release and the vaginal absorption profiles of flurogestone acetate from the vaginal devices.

The design, development and the simultaneous release and absorption profiles of flurogestone acetate from this new vaginal device were outlined and discussed.
Keywords:
本文献已被 InformaWorld 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号